Seres Therapeutics
MCRB
#10246
Rank
NZ$5.45 M
Marketcap
$0.63
Share price
1.11%
Change (1 day)
-59.18%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -$1.78

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.87. In 2022 the company made an earnings per share (EPS) of -$3.91 a decrease over its 2021 EPS that were of -$1.22.

EPS history for Seres Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.78-54.41%
2022-$3.91220.55%
2021-$1.22-34.23%
2020-$1.86-15.27%
2019-$2.19-46.09%
2018-$4.069.95%
2017-$3.69-3.49%
2016-$3.83-10.19%
2015-$4.26321.85%
2014-$1.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.58 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.60 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA